These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Non-alcoholic fatty liver disease and diabetes. Reyes-García R; Rozas-Moreno P; Llamoza-Torres CJ; Mezquita-Raya P Med Clin (Barc); 2017 Jan; 148(1):33-38. PubMed ID: 27751514 [No Abstract] [Full Text] [Related]
33. Management of NAFLD: a stage-based approach. Rinella ME; Sanyal AJ Nat Rev Gastroenterol Hepatol; 2016 Apr; 13(4):196-205. PubMed ID: 26907882 [TBL] [Abstract][Full Text] [Related]
34. [Diagnosis and therapeutic strategies for non-alcoholic fatty liver disease in children]. Li J; Ren WH Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):208-212. PubMed ID: 32306653 [TBL] [Abstract][Full Text] [Related]
35. The benefits of exercise for patients with non-alcoholic fatty liver disease. Keating SE; George J; Johnson NA Expert Rev Gastroenterol Hepatol; 2015; 9(10):1247-50. PubMed ID: 26289101 [TBL] [Abstract][Full Text] [Related]
36. Incidence of non-alcoholic fatty liver disease in Hong Kong: a population study with paired proton-magnetic resonance spectroscopy. Wong VW; Wong GL; Yeung DK; Lau TK; Chan CK; Chim AM; Abrigo JM; Chan RS; Woo J; Tse YK; Chu WC; Chan HL J Hepatol; 2015 Jan; 62(1):182-9. PubMed ID: 25195550 [TBL] [Abstract][Full Text] [Related]
37. Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age. Shen Z; Munker S; Luo F; Ma H; Yu C; Li Y PLoS One; 2015; 10(6):e0130614. PubMed ID: 26087253 [TBL] [Abstract][Full Text] [Related]